Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $75 - $88
3 Added 0.02%
18,571 $520,000
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $256,958 - $295,070
9,925 Added 114.83%
18,568 $515,000
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $54,533 - $70,832
2,087 Added 31.83%
8,643 $249,000
Q3 2023

Nov 15, 2023

SELL
$32.09 - $37.51 $46,498 - $54,351
-1,449 Reduced 18.1%
6,556 $217,000
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $68,086 - $78,774
1,885 Added 30.8%
8,005 $294,000
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $4,017 - $5,230
-102 Reduced 1.64%
6,120 $250,000
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $7,807 - $10,191
-187 Reduced 2.92%
6,222 $319,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $87 - $106
2 Added 0.03%
6,409 $280,000
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $44,901 - $53,239
965 Added 17.73%
6,407 $336,000
Q1 2022

May 12, 2022

SELL
$45.75 - $56.69 $216,168 - $267,860
-4,725 Reduced 46.47%
5,442 $282,000
Q4 2021

Feb 11, 2022

SELL
$41.32 - $61.25 $54,790 - $81,217
-1,326 Reduced 11.54%
10,167 $600,000
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $11,853 - $15,226
-302 Reduced 2.56%
11,493 $494,000
Q2 2021

Aug 17, 2021

BUY
$35.91 - $40.68 $39,572 - $44,829
1,102 Added 10.31%
11,795 $462,000
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $9,477 - $10,688
-283 Reduced 2.58%
10,693 $387,000
Q4 2020

Feb 09, 2021

BUY
$33.47 - $42.56 $367,366 - $467,138
10,976 New
10,976 $404,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Annandale Capital, LLC Portfolio

Follow Annandale Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Annandale Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Annandale Capital, LLC with notifications on news.